Travere Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-14.8M | $-19.9M | $5.1M | $29.6M |
| FY2022 | $-186.3M | $-186.5M | $191.0K | $38.1M |
| FY2023 | $-280.0M | $-280.7M | $668.0K | $44.2M |
| FY2024 | $-237.5M | $-237.5M | — | $36.9M |
| FY2025 | $37.8M | $37.8M | — | $44.9M |